Cg Oncology Inc (NASDAQ: CGON) kicked off on Tuesday, down -4.78% from the previous trading day, before settling in for the closing price of $39.75. Over the past 52 weeks, CGON has traded in a range of $14.80-$46.01.
While this was happening, its average annual earnings per share was recorded -54.47%. With a float of $50.68 million, this company’s outstanding shares have now reached $78.28 million.
Let’s look at the performance matrix of the company that is accounted for 113 employees.
Cg Oncology Inc (CGON) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cg Oncology Inc is 37.18%, while institutional ownership is 76.88%. The most recent insider transaction that took place on Nov 17 ’25, was worth 41,430. In this transaction Director of this company sold 1,000 shares at a rate of $41.43, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 13 ’25, when Company’s Director sold 1,000 for $43.25, making the entire transaction worth $43,250. This insider now owns 0 shares in total.
Cg Oncology Inc (CGON) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.48 earnings per share (EPS), lower than consensus estimate (set at -0.46) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -54.47% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Take a look at Cg Oncology Inc’s (CGON) current performance indicators. Last quarter, stock had a quick ratio of 22.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1407.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.98, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.60 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Cg Oncology Inc (NASDAQ: CGON) saw its 5-day average volume 0.6 million, a negative change from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 4.78%.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 63.51%, which indicates a significant increase from 1.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.07 in the past 14 days, which was higher than the 1.95 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.90, while its 200-day Moving Average is $30.72. Nevertheless, the first resistance level for the watch stands at $39.40 in the near term. At $40.94, the stock is likely to face the second major resistance level. The third major resistance level sits at $41.77. If the price goes on to break the first support level at $37.02, it is likely to go to the next support level at $36.19. The third support level lies at $34.65 if the price breaches the second support level.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
The company with the Market Capitalisation of 3.05 billion has total of 80,666K Shares Outstanding. Its annual sales at the moment are 1,140 K in contrast with the sum of -88,040 K annual income. Company’s last quarter sales were recorded 1,670 K and last quarter income was -43,810 K.
